Difference between revisions of "Team:Gifu/team-profile"

 
(11 intermediate revisions by the same user not shown)
Line 80: Line 80:
  
  
−
<table width="800" style="border: currentColor; border-image: none; margin-right: auto; margin-left: auto;" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td width="30%" nowrap="" style="text-align: left; padding-right: 2em;"><b>Team Status</b><td align="center"><td width="30%" align="right"></tr></tbody></table><table width="800" id="table_status" style="padding: 3px 2px 0px 15px; border: 1px solid gray; border-image: none; line-height: 150%; margin-right: auto; margin-left: auto; background-color: rgb(220, 220, 220);" border="0" cellspacing="0" cellpadding="0">
+
<TABLE width='800' border='0' cellspacing='0' cellpadding='0' style='margin-left:auto; margin-right:auto; border: none;'><TR><TD nowrap width='30%' style='padding-right: 2em;text-align: left;'><B>Team Status</B><TD align='center'><TD width='30%' align='right'></TABLE><TABLE id='table_status' width='800' border='0' cellspacing='0' cellpadding='0' style='margin-left:auto; margin-right:auto; border: 1px solid gray;background-color: #dcdcdc; padding-left: 10px;padding:10px 15px 0px 15px;line-height: 150%; padding-right:2px;padding-top:3px;' >
−
<tbody><tr><td style="color: rgb(0, 102, 0);">
+
<TR><TD style='color:#006600;font-size:120%,padding:5px 0 5px 0'>
−
                 <b>Welcome to iGEM 2015 !</b> Your iGEM 2015 team application was accepted by iGEM Headquarters on 2015-05-02 08:32:07
+
                 <B>Welcome to iGEM 2015 !</B> Your iGEM 2015 team application was accepted by iGEM Headquarters on 2015-05-02 08:32:07
−
                 and your team registration fee has been received.</tr></tbody></table><div style="height: 3px;"></div><table_break></table_break><table width="800" id="table_status" style="padding: 3px 2px 0px 15px; border: 1px solid gray; border-image: none; line-height: 150%; margin-right: auto; margin-left: auto; background-color: rgb(220, 220, 220);" border="0" cellspacing="0" cellpadding="0">
+
                 and your team registration fee has been received.</TABLE><DIV style='height: 3px'></DIV><TABLE id='table_status' width='800' border='0' cellspacing='0' cellpadding='0' style='margin-left:auto; margin-right:auto; border: 1px solid gray;background-color: #dcdcdc; padding-left: 10px;padding:10px 15px 0px 15px;line-height: 150%; padding-right:2px;padding-top:3px;' >
−
<tbody><tr><td><img src="https://igem.org/images/green_check.png"> DNA Kit of Parts shipping information has been entered, thanks.
+
<TABLE_BREAK><TR><TD><img src='https://igem.org/images/green_check.png'> DNA Kit of Parts shipping information has been entered, thanks.
−
                 <a href="Shipping.cgi?group_id=1707"><i> View shipping information</i></a><tr><td><img src="https://igem.org/images/green_check.png"> Resource description has been submitted, thanks.
+
                 <A href='Shipping.cgi?group_id=2287'><I> View shipping information</I></A><TR><TD><img src='https://igem.org/images/green_check.png'> Resource description has been submitted, thanks.
−
                 <a href="Resource_Description.cgi?group_id=1707"><i> View resource description</i></a><tr><td><img src="https://igem.org/images/green_check.png"> Your registration fee has been received. Thank you.
+
                 <A href='Resource_Description.cgi?group_id=2287'><I> View resource description</I></A><TR><TD><img src='https://igem.org/images/green_check.png'> Your registration fee has been received. Thank you.
−
                 <a href="https://2015.igem.org/Team_Registration_Fee"><i> More...</i></a><table_break>
+
                 <A href='https://2015.igem.org/Team_Registration_Fee'><I> More...</I></A><TABLE_BREAK>
−
</table_break></tr></tbody></table><br>
+
</TABLE><BR>
 +
 
 +
<!-- safety -->
 +
 
 +
 
 +
<TABLE width='800' border='0' cellspacing='0' cellpadding='0' style='margin-left:auto; margin-right:auto; border: none;'><TR><TD nowrap width='30%' style='padding-right: 2em;text-align: left;'><B>Safety</B><TD align='center'><TD width='30%' align='right'></TABLE><TABLE id='table_safety' width='800' border='0' cellspacing='0' cellpadding='0' style='margin-left:auto; margin-right:auto; border: 1px solid gray;background-color: #dcdcdc; padding-left: 10px;padding:10px 15px 0px 15px;line-height: 150%; padding-right:2px;padding-top:3px;' >
 +
 
 +
<TR><TD colspan=9><A style='padding-left:40px' href='https://2015.igem.org/Safety/Check_In?team_id=1859'>Check In Form</A><A style='padding-left:40px' href='https://2015.igem.org/Safety/About_Our_Lab?team_id=1859'>About Our Lab Form</A><A style='padding-left:40px' href='https://2015.igem.org/Safety/About_Our_Project?team_id=1859'>About Our Project Form</A><A style='padding-left:40px' href='https://2015.igem.org/Safety/Final_Safety_Form?team_id=1859'>Final Safety Form</A>
 +
</TABLE><BR>
 +
 
 +
 
 +
 
  
 
<!-- tracks -->
 
<!-- tracks -->
Line 100: Line 111:
  
  
−
<table width="800" style="border: currentColor; border-image: none; margin-right: auto; margin-left: auto;" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td width="30%" nowrap="" style="text-align: left; padding-right: 2em;"><b>Title and Abstract</b><a style="color: rgb(102, 102, 255); padding-left: 15px; font-size: 90%;" href="https://2015.igem.org/Jamboree/Title_and_Abstract"><i>More...</i></a><td align="center"><a style="color: blue; text-decoration: none;" href="abstract_pdf_file.cgi?id=1332"><i>Download a .pdf version</i></a><td width="30%" align="right"></tr></tbody></table><table width="800" id="table_abstract" style="padding: 3px 2px 0px 15px; border: 1px solid gray; border-image: none; line-height: 150%; margin-right: auto; margin-left: auto; background-color: rgb(220, 220, 220);" border="0" cellspacing="0" cellpadding="0">
+
<table width="800" style="border: currentColor; border-image: none; margin-right: auto; margin-left: auto;" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td width="30%" nowrap="" style="text-align: left; padding-right: 2em;"><b>Title and Abstract</b><a style="color: rgb(102, 102, 255); padding-left: 15px; font-size: 90%;" href="https://2015.igem.org/Jamboree/Title_and_Abstract"><i>More...</i></a><td align="center"><A style='text-decoration: none; color: blue;'
 +
            HREF='abstract_pdf_file.cgi?id=1859' ><i>Download a .pdf version</i></a><td width="30%" align="right"></tr></tbody></table><table width="800" id="table_abstract" style="padding: 3px 2px 0px 15px; border: 1px solid gray; border-image: none; line-height: 150%; margin-right: auto; margin-left: auto; background-color: rgb(220, 220, 220);" border="0" cellspacing="0" cellpadding="0">
 +
 
 +
<tbody><tr><td style="padding: 5px 0px; width: 750px; font-size: 10pt; font-weight: bold;" colspan="9">Circular mRNA ver.2.0<br>
 +
<tr><td style="padding: 5px 0px 5px 20px; width: 750px; vertical-align: top;" colspan="9"> &#12288;In last year, we succeeded in designing the sequence which synthesizes circular mRNA and long chain protein in <i>Escherichia coli</i>.<br>
 +
 
 +
 
 +
&#12288;In this year, we had 2 purposes in our study. One was an efficiency of the circularization. The efficiency was lower in our previous study. This was why the splicing was hard to happen because two sequences to act as ribozyme for splicing were far each other. So we incorporated <b>complementary sequences</b> around the ribozyme regions. We thought that the treatment brought two regions close and the efficiency of the circularization improved.<br>
  
−
<tbody><tr><td style="padding: 5px 0px; width: 750px; font-size: 10pt; font-weight: bold;" colspan="9">Circular mRNA ver2<br>
+
The other was to synthesize useful proteins. In our previous study, synthesized long-chain proteins lose their function because the folding of the proteins was broken. So we incorporated <b>linker sequences</b> into circular mRNA to synthesize the functional long-chain protein.<br></tr></tbody></table><br>
−
<tr><td style="padding: 5px 0px 5px 20px; width: 750px; vertical-align: top;" colspan="9"> &#12288;In last year, we succeeded in designing the sequence which synthesizes circular mRNA and long chain protein in
+
−
Escherichia coli.<br>
+
−
&#12288;In this year, we had 2 purposes in our study. One was an efficiency of the circularization. The efficiency was
+
−
lower in our previous study. This was why the splicing was hard to happen because two sequences to act as ribozyme for
+
−
splicing were far each other. So we incorporated complementary sequences around the ribozyme regions. We thought that
+
−
the treatment brought two regions close and the efficiency of the circularization improved.<br>
+
−
&#12288;The other was to synthesize useful proteins. In our previous study, synthesized long-chain proteins lose their function
+
−
because the folding of the proteins was broken. So we incorporated linker sequences into circular mRNA to synthesize the
+
−
functional long-chain protein.<br></tr></tbody></table><br>
+
 
<style>
 
<style>
 
.form_roster td { font-size:95% }
 
.form_roster td { font-size:95% }
Line 184: Line 193:
 
<!-- Non-editable Member 23896 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=20592">momochi</a><td style="width: 200px;">Momoko YAMADA<td><td>
 
<!-- Non-editable Member 23896 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=20592">momochi</a><td style="width: 200px;">Momoko YAMADA<td><td>
  
−
<!-- Non-editable Member 23899 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=20596">Kairi</a><td style="width: 200px;">Kairi ISHIMARU<td><td>
+
<!-- Non-editable Member 23899 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=26709">Kairi</a><td style="width: 200px;">Kairi ISHIMARU<td><td>
  
 
<!-- Non-editable Member 23895 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=20591">nomuken</a><td style="width: 200px;">Nomura Kenta<td><td>
 
<!-- Non-editable Member 23895 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=20591">nomuken</a><td style="width: 200px;">Nomura Kenta<td><td>
Line 190: Line 199:
 
<!-- Non-editable Member 23897 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=20593">kozakai</a><td style="width: 200px;">Kozakai Tomoya<td><td>
 
<!-- Non-editable Member 23897 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=20593">kozakai</a><td style="width: 200px;">Kozakai Tomoya<td><td>
  
−
<!-- Non-editable Member 24477 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=21022">fumiki</a><td style="width: 200px;">Fumiki Izumi<td><td>
+
<!-- Non-editable Member 24477 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=26712">fumiki</a><td style="width: 200px;">Fumiki Izumi<td><td>
  
−
<!-- Non-editable Member 24761 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=21240">liyu</a><td style="width: 200px;">son liyu<td><td>
+
<!-- Non-editable Member 24761 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=26710">liyu</a><td style="width: 200px;">son liyu<td><td>
−
</tr></tbody></table><br>
+
  
−
<!-- Non-editable Member 24761 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=21240">FreshLemon</a><td style="width: 200px;">Haruka Maruyama<td><td>
+
<!-- Non-editable Member 24761 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=26711">FreshLemon</a><td style="width: 200px;">Haruka Maruyama<td><td>
−
</tr></tbody></table><br>
+
  
 
<!-- Non-editable Member 23901 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=20597">takema</a><td style="width: 200px;">Hasegawa Takema<td><td>
 
<!-- Non-editable Member 23901 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=20597">takema</a><td style="width: 200px;">Hasegawa Takema<td><td>
Line 208: Line 215:
 
<!-- Non-editable Member 23900 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=20595">SachiA</a><td style="width: 200px;">Sachi Asano<td><td>
 
<!-- Non-editable Member 23900 --><tr><td style="width: 150px; padding-left: 10px;"><a href="User_Information.cgi?user_id=20595">SachiA</a><td style="width: 200px;">Sachi Asano<td><td>
  
 +
</tr></tbody></table><br>
  
  
Line 220: Line 228:
  
 
<table width="800" id="table_ranges" style="padding: 3px 2px 0px 15px; border: 1px solid gray; border-image: none; line-height: 150%; margin-right: auto; margin-left: auto; background-color: rgb(220, 220, 220);" border="0" cellspacing="0" cellpadding="0">
 
<table width="800" id="table_ranges" style="padding: 3px 2px 0px 15px; border: 1px solid gray; border-image: none; line-height: 150%; margin-right: auto; margin-left: auto; background-color: rgb(220, 220, 220);" border="0" cellspacing="0" cellpadding="0">
−
<tbody><tr><td>This range of part numbers has been assigned to your team for use during the summer: <span style="margin-left: 10px;">BBa_K1332000 to BBa_K1332999</span>
+
<tbody><tr><td>This range of part numbers has been assigned to your team for use during the summer: <span style="margin-left: 10px;">BBa_K1859000 to BBa_K1859999 </span>
 
</tr></tbody></table><br>
 
</tr></tbody></table><br>
 
<!-- end content -->
 
<!-- end content -->

Latest revision as of 03:36, 18 September 2015



https://static.igem.org/mediawiki/2015/d/d8/Logo_HOME.png https://static.igem.org/mediawiki/2015/a/a4/Logo_PROJECT.png https://static.igem.org/mediawiki/2015/archive/b/b9/20150720104417%21Logo_TEAM.png https://static.igem.org/mediawiki/2015/8/86/Logo_NOTE.png https://static.igem.org/mediawiki/2015/8/87/Logo_RESULT.png https://static.igem.org/mediawiki/2015/2/28/Logo_MORE.png



TEAM PROFILE


Team Name: Gifu
Primary Contact (PI): Hitoshi IWAHASHI
Schools:
Gifu University
Yanagido, Gifu, Japan
Division:iGEMApplication Date:  2015-04-27
Section:Undergraduate
Region:AsiaAcceptance Date: 2015-05-02 08:32:07
Description:

Team Status
Welcome to iGEM 2015 ! Your iGEM 2015 team application was accepted by iGEM Headquarters on 2015-05-02 08:32:07 and your team registration fee has been received.
DNA Kit of Parts shipping information has been entered, thanks. View shipping information
Resource description has been submitted, thanks. View resource description
Your registration fee has been received. Thank you. More...

Safety
Check In FormAbout Our Lab FormAbout Our Project FormFinal Safety Form

TrackMore...
Assigned Track: New Application

Title and AbstractMore...Download a .pdf version
Circular mRNA ver.2.0
　In last year, we succeeded in designing the sequence which synthesizes circular mRNA and long chain protein in Escherichia coli.
　In this year, we had 2 purposes in our study. One was an efficiency of the circularization. The efficiency was lower in our previous study. This was why the splicing was hard to happen because two sequences to act as ribozyme for splicing were far each other. So we incorporated complementary sequences around the ribozyme regions. We thought that the treatment brought two regions close and the efficiency of the circularization improved.
The other was to synthesize useful proteins. In our previous study, synthesized long-chain proteins lose their function because the folding of the proteins was broken. So we incorporated linker sequences into circular mRNA to synthesize the functional long-chain protein.

Team Roster
Instructors
h1884Hitoshi IWAHASHI
isatoshiSatoshi IWAMOTO
aebihara2014Akio Ebihara
Student Members
momochiMomoko YAMADA
KairiKairi ISHIMARU
nomukenNomura Kenta
kozakaiKozakai Tomoya
fumikiFumiki Izumi
liyuson liyu
FreshLemonHaruka Maruyama
takemaHasegawa Takema
ybannoYusuke Banno
MoriAkihiro Moriyama
fukufukuWataru Fukuda
SachiASachi Asano

This range of part numbers has been assigned to your team for use during the summer: BBa_K1859000 to BBa_K1859999